Sialylation of Campylobacter jejuni endotoxin promotes dendritic cell-mediated B cell responses through CD14-dependent production of IFN-β and TNF-α

Journal of Immunology

Volumn 191, Issue 11, 2013, Pages 5636-5645

  Huizinga, Ruth ^a   Van Rijs, Wouter ^a   Bajramovic, Jeffrey J ^b   Kuijf, Mark L ^a,c   Laman, Jon D ^a   Samsom, Janneke N ^a   Jacobs, Bart C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; BETA INTERFERON; CD14 ANTIGEN; ENDOTOXIN; LIPOOLIGOSACCHARIDE; SIALIC ACID; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; B LYMPHOCYTE; CAMPYLOBACTER JEJUNI; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; SIALYLATION;

EID: 84888381600     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301536     Document Type: Article

References (49)

1. Havelaar, A. H., W. van Pelt, C. W. Ang, J. A. Wagenaar, J. P. van Putten, U. Gross, and D. G. Newell. 2009. Immunity to Campylobacter: its role in risk assessment and epidemiology. Crit. Rev. Microbiol. 35: 1-22.
2. Guerry, P., C. M. Szymanski, M. M. Prendergast, T. E. Hickey, C. P. Ewing, D. L. Pattarini, and A. P. Moran. 2002. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect. Immun. 70: 787-793.
3. Prendergast, M. M., D. R. Tribble, S. Baqar, D. A. Scott, J. A. Ferris, R. I. Walker, and A. P. Moran. 2004. In vivo phase variation and serologic response to lipooligosaccharide of Campylobacter jejuni in experimental human infection. Infect. Immun. 72: 916-922.
4. Gilbert, G. L., C. T. Parker, and A. P. Moran. 2008. Campylobacter jejuni lipooligosaccharides: stuctures and biosynthesis. In Campylobacter, 3rd Ed. I. Nachamkin C. M. Szymanski, and M. J. Blaser, eds. ASM Press, Washington, D.C., p. 483-504.
5. Varki, A., and P. Gagneux. 2012. Multifarious roles of sialic acids in immunity. Ann. N. Y. Acad. Sci. 1253: 16-36.
6. Louwen, R., A. Heikema, A. van Belkum, A. Ott, M. Gilbert, W. Ang, H. P. Endtz, M. P. Bergman, and E. E. Nieuwenhuis. 2008. The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion. Infect. Immun. 76: 4431-4438.
7. Guerry, P., C. P. Ewing, T. E. Hickey, M. M. Prendergast, and A. P. Moran. 2000. Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni. Infect. Immun. 68: 6656-6662.
8. Blaser, M. J., P. F. Smith, and P. F. Kohler. 1985. Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J. Infect. Dis. 151: 227-235.
9. Mortensen, N. P., M. L. Kuijf, C. W. Ang, P. Schiellerup, K. A. Krogfelt, B. C. Jacobs, A. van Belkum, H. P. Endtz, and M. P. Bergman. 2009. Sialylation of Campylobacter jejuni lipo-oligosaccharides is associated with severe gastroenteritis and reactive arthritis. Microbes Infect. 11: 988-994.
10. van Belkum, A., N. van den Braak, P. Godschalk, W. Ang, B. Jacobs, M. Gilbert, W. Wakarchuk, H. Verbrugh, and H. Endtz. 2001. A Campylobacter jejuni gene associated with immune-mediated neuropathy. Nat. Med. 7: 752-753.
11. Yuki, N., K. Susuki, M. Koga, Y. Nishimoto, M. Odaka, K. Hirata, K. Taguchi, T. Miyatake, K. Furukawa, T. Kobata, and M. Yamada. 2004. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc. Natl. Acad. Sci. USA 101: 11404-11409.
12. de Zoete, M. R., A. M. Keestra, P. Roszczenko, and J. P. van Putten. 2010. Activation of human and chicken toll-like receptors by Campylobacter spp. Infect. Immun. 78: 1229-1238.
13. Rathinam, V. A., D. M. Appledorn, K. A. Hoag, A. Amalfitano, and L. S. Mansfield. 2009. Campylobacter jejuni -induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes. Infect. Immun. 77: 2499-2507.
14. Kuijf, M. L., J. N. Samsom, W. van Rijs, M. Bax, R. Huizinga, A. P. Heikema, P. A. van Doorn, A. van Belkum, Y. van Kooyk, P. C. Burgers, et al. 2010. TLR4- mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. J. Immunol. 185: 748-755.
15. Huizinga, R., A. S. Easton, A. M. Donachie, J. Guthrie, W. van Rijs, A. Heikema, L. Boon, J. N. Samsom, B. C. Jacobs, H. J. Willison, and C. S. Goodyear. 2012. Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice. PLoS ONE 7: e34416.
16. Lee, C. C., A. M. Avalos, and H. L. Ploegh. 2012. Accessory molecules for Toll-like receptors and their function. Nat. Rev. Immunol. 12: 168-179.
17. Craxton, A., D. Magaletti, E. J. Ryan, and E. A. Clark. 2003. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101: 4464-4471.
18. Litinskiy, M. B., B. Nardelli, D. M. Hilbert, B. He, A. Schaffer, P. Casali, and A. Cerutti. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3: 822-829.
19. Balázs, M., F. Martin, T. Zhou, and J. Kearney. 2002. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17: 341-352.
20. Godschalk, P. C., M. L. Kuijf, J. Li, F. St Michael, C. W. Ang, B. C. Jacobs, M. F. Karwaski, D. Brochu, A. Moterassed, H. P. Endtz, et al. 2007. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barré and Miller Fisher syndromes. Infect. Immun. 75: 1245-1254.
21. Godschalk, P. C., A. P. Heikema, M. Gilbert, T. Komagamine, C. W. Ang, J. Glerum, D. Brochu, J. Li, N. Yuki, B. C. Jacobs, et al. 2004. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain- Barré syndrome. J. Clin. Invest. 114: 1659-1665.
22. Mond, J. J., and M. Brunswick. 2003. Proliferative assays for B cell function. Curr. Protoc. Immunol. Chapter 3: Unit 3.10.
23. Hardenberg, G., L. Planelles, C. M. Schwarte, L. van Bostelen, T. Le Huong, M. Hahne, and J. P. Medema. 2007. Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR-dependent manner. Eur. J. Immunol. 37: 2900-2911.
24. Jiang, Z., P. Georgel, X. Du, L. Shamel, S. Sovath, S. Mudd, M. Huber, C. Kalis, S. Keck, C. Galanos, et al. 2005. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6: 565-570.
25. Uronen-Hansson, H., J. Allen, M. Osman, G. Squires, N. Klein and R. E. Callard. 2004. Toll-like receptor 2 (TLR2) and TLR4 are present inside human dendritic cells, associated with microtubules and the Golgi apparatus but are not detectable on the cell surface: integrity of microtubules is required for interleukin-12 production in response to internalized bacteria. Immunology 111: 173-178.
26. Jacobs, B. C., P. H. Rothbarth, F. G. van der Meché, P. Herbrink, P. I. Schmitz, M. A. de Klerk, and P. A. van Doorn. 1998. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 51: 1110-1115.
27. Rousset, F., E. Garcia, T. Defrance, C. Péronne, N. Vezzio, D. H. Hsu, R. Kastelein, K. W. Moore, and J. Banchereau. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89: 1890-1893.
28. Zhu, J., X. Huang, and Y. Yang. 2007. Type I IFN signaling on both B and CD4 T cells is required for protective antibody response to adenovirus. J. Immunol. 178: 3505-3510.
29. Tezuka, H., Y. Abe, J. Asano, T. Sato, J. Liu, M. Iwata, and T. Ohteki. 2011. Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction. Immunity 34: 247-257.
30. Bergtold, A., D. D. Desai, A. Gavhane, and R. Clynes. 2005. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 23: 503-514.
31. Qi, H., J. G. Egen, A. Y. Huang, and R. N. Germain. 2006. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312: 1672-1676.
32. Bereswill, S., A. Fischer, R. Plickert, L. M. Haag, B. Otto, A. A. Kühl, J. I. Dasti, A. E. Zautner, M. Muñoz, C. Loddenkemper, et al. 2011. Novel murine infection models provide deep insights into the "ménage à trois" of Campylobacter jejuni, microbiota and host innate immunity. Published erratum appears in 2011 PLoS One. DOI: 10.1371/annotation/5247af81-4595-44b7-9c3f-2e45ad85abfa]. PLoS ONE 6: e20953.
33. Zanoni, I., C. Bodio, A. Broggi, R. Ostuni, M. Caccia, M. Collini, A. Venkatesh, R. Spreafico, G. Capuano, and F. Granucci. 2012. Similarities and differences of innate immune responses elicited by smooth and rough LPS. Immunol. Lett. 142: 41-47.
34. Stephenson, H. N., C. M. John, N. Naz, O. Gundogdu, N. Dorrell, B. W. Wren, G. A. Jarvis, and M. Bajaj-Elliott. 2013. Campylobacter jejuni lipooligosaccharide sialylation, phosphorylation, and amide/ester linkage modifications fine-tune human Toll-like receptor 4 activation. J. Biol. Chem. 288: 19661-19672.
35. Jahr, T. G., A. Sundan, H. S. Lichenstein, and T. Espevik. 1995. Influence of CD14, LBP and BPI in the monocyte response to LPS of different polysaccharide chain length. Scand. J. Immunol. 42: 119-127.
36. Hornef, M. W., T. Frisan, A. Vandewalle, S. Normark, and A. Richter-Dahlfors. 2002. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med. 195: 559-570.
37. Guillot, L., S. Medjane, K. Le-Barillec, V. Balloy, C. Danel, M. Chignard, and M. Si-Tahar. 2004. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J. Biol. Chem. 279: 2712-2718.
38. Tsukamoto, H., K. Fukudome, S. Takao, N. Tsuneyoshi, and M. Kimoto. 2010. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells. Int. Immunol. 22: 271-280.
39. Tanimura, N., S. Saitoh, F. Matsumoto, S. Akashi-Takamura, and K. Miyake. 2008. Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem. Biophys. Res. Commun. 368: 94-99.
40. Wang, L., E. Trebicka, Y. Fu, L. Waggoner, S. Akira, K. A. Fitzgerald, J. C. Kagan, and B. J. Cherayil. 2011. Regulation of lipopolysaccharide-induced translation of tumor necrosis factor-alpha by the toll-like receptor 4 adaptor protein TRAM. J. Innate Immun. 3: 437-446.
41. Bax, M., M. L. Kuijf, A. P. Heikema, W. van Rijs, S. C. Bruijns, J. J. García-Vallejo, P. R. Crocker, B. C. Jacobs, S. J. van Vliet, and Y. van Kooyk. 2011. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner. Infect. Immun. 79: 2681-2689.
42. Heikema, A. P., R. I. Koning, S. Duarte dos Santos Rico, H. Rempel, B. C. Jacobs, H. P. Endtz, W. J. van Wamel, and J. N. Samsom. 2013. Enhanced, sialoadhesin-dependent uptake of Guillain-Barré syndrome-associated Campylobacter jejuni strains by human macrophages. Infect. Immun. 81: 2095-2103.
43. Klaas, M., C. Oetke, L. E. Lewis, L. P. Erwig, A. P. Heikema, A. Easton, H. J. Willison, and P. R. Crocker. 2012. Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni. J. Immunol. 189: 2414-2422.
44. Heikema, A. P., B. C. Jacobs, D. Horst-Kreft, R. Huizinga, M. L. Kuijf, H. P. Endtz, J. N. Samsom, and W. J. van Wamel. 2013. Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndrome. Clin. Microbiol. Infect. 19: E106-E112.
45. Avril, T., E. R. Wagner, H. J. Willison, and P. R. Crocker. 2006. Sialic acidbinding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infect. Immun. 74: 4133-4141.
46. Pillai, S., H. Mattoo, and A. Cariappa. 2011. B cells and autoimmunity. Curr. Opin. Immunol. 23: 721-731.
47. Braun, D., I. Caramalho, and J. Demengeot. 2002. IFN-alpha/beta enhances BCR-dependent B cell responses. Int. Immunol. 14: 411-419.
48. Kono, D. H., M. K. Haraldsson, B. R. Lawson, K. M. Pollard, Y. T. Koh, X. Du, C. N. Arnold, R. Baccala, G. J. Silverman, B. A. Beutler, and A. N. Theofilopoulos. 2009. Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc. Natl. Acad. Sci. USA 106: 12061-12066.
49. Thibault, D. L., K. L. Graham, L. Y. Lee, I. Balboni, P. J. Hertzog, and P. J. Utz. 2009. Type I interferon receptor controls B-cell expression of nucleic acidsensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Res. Ther. 11: R112.